文献速递儿科影像腹部泌尿生殖MR

扩散加权MRI在肾母细胞瘤评估中的价值:一项多中心试验结果

Diffusion-weighted MRI in the assessment of nephroblastoma: results of a multi-center trial.
PubMed 文献 · Abdom Radiol (NY) · 2020-01-01

这项经IRB批准的回顾性多中心研究纳入122例患儿共130个肾脏肿瘤,在新辅助化疗和肾切除术前行含DWI的MRI检查,两位放射科医师独立进行体积测量和基于体素的ADC计算,包括直方图和纹理分析参数。结果显示DWI可能有助于识别良性肾母细胞瘤病和评估肾母细胞瘤亚型,作者认为需进一步研究其在儿童肾肿瘤风险分层中的价值。

要点

  • 局部侵袭性生长(SIOP 3期)或转移(M1)患者第12.5百分位ADC值显著低于低分期肿瘤(p≤0.028)。
  • M1与M0患者间纹理参数energy差异显著(p≤0.028)。
  • 对比度和均匀性在良性肾母细胞瘤病与恶性肾母细胞瘤间差异显著(p≤0.045)。

关键影像表现/征象

  • 局部侵袭性生长(SIOP 3期)或转移(M1)患者第12.5百分位ADC值显著低于低分期肿瘤患者(p≤0.028,两位阅片者)。
  • M1患者与M0患者间纹理参数energy差异显著(p≤0.028)。
  • 良性肾母细胞瘤病与恶性肾母细胞瘤间对比度和均匀性差异显著(p≤0.045,两位阅片者)。
  • 与所有其他亚型相比,胚芽型亚型偏度显著更高(p≤0.022,两位阅片者)。
  • 与所有其他亚型相比,弥漫间变型亚型第75百分位ADC值显著更高(p≤0.042,两位阅片者)。

诊断标准与关键数值

  • 阅片者间一致性优秀(ICC 0.717-0.975)。
  • 局部侵袭性生长(SIOP 3期)或转移(M1)患者第12.5百分位ADC值显著低于低分期肿瘤患者(p≤0.028)。
  • M1与M0患者间纹理参数energy差异显著(p≤0.028)。
  • 良性肾母细胞瘤病与恶性肾母细胞瘤间对比度和均匀性差异显著(p≤0.045)。
  • 胚芽型亚型偏度显著高于其他亚型(p≤0.022),弥漫间变型亚型第75百分位ADC值显著高于其他亚型(p≤0.042)。

临床应用与阅片要点

  • 作者认为扩散加权MRI可能有助于识别良性肾母细胞瘤病和评估肾母细胞瘤亚型。
  • 作者认为需进一步研究评估其在儿童肾肿瘤风险分层中的价值。

局限性

  • 原文结论指出需进一步研究评估其在儿童肾肿瘤风险分层中的价值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To assess the value of diffusion-weighted MRI in the pre-therapeutic evaluation of pediatric renal cortical tumors.

METHODS: This IRB-approved, retrospective multi-center study included 122 pediatric patients with 130 renal tumors, who underwent MRI including DWI before neoadjuvant chemotherapy and nephrectomy. Two radiologists independently assessed each tumor volumetrically, and apparent diffusion coefficient (ADC) values were calculated on a voxel-wise basis, including parameters derived from histogram and texture analysis.

RESULTS: Inter-reader agreement was excellent (ICC 0.717-0.975). For both readers, patients with locally aggressive tumor growth (SIOP 3 stage) or with metastases (M1) had significantly lower 12.5th-percentile ADC values (p ≤ 0.028) compared to those with lower-stage tumors, and the parameter energy differed significantly between patients with M1 and those with M0 status (p ≤ 0.028). Contrast and homogeneity differed significantly between benign nephroblastomatosis and malignant nephroblastoma (p ≤ 0.045, both readers). As compared to all other subtypes, the blastemal subtype demonstrated significantly higher skewness (p ≤ 0.022, both readers) and the diffuse anaplastic subtype demonstrated significantly higher 75th-percentile ADC values (p ≤ 0.042, both readers).

CONCLUSIONS: Diffusion-weighted MRI may be of value in identifying benign nephroblastomatosis and assessing nephroblastoma subtypes. Therefore, further research is warranted to assess its value in risk stratification for pediatric patients with renal tumors in the future.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Hötker AM, Lollert A, Mazaheri Y, et al. Diffusion-weighted MRI in the assessment of nephroblastoma: results of a multi-center trial. Abdom Radiol (NY). 2020. PMID: 32166338. doi:10.1007/s00261-020-02475-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。